Aberdeen Group’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $70.8M | Sell |
836,940
-139,099
| -14% | -$11.2M | 0.1% | 162 |
|
|
2026
Q1 | $69M | Buy |
976,039
+120,240
| +14% | +$9M | 0.11% | 165 |
|
|
2025
Q4 | $67.6M | Buy |
855,799
+39,512
| +5% | +$3.13M | 0.1% | 156 |
|
|
2025
Q3 | $66.6M | Sell |
816,287
-75,275
| -8% | -$5.92M | 0.11% | 160 |
|
|
2025
Q2 | $71.7M | Sell |
891,562
-130,712
| -13% | -$10.1M | 0.12% | 153 |
|
|
2025
Q1 | $81.3M | Buy |
1,022,274
+78,069
| +8% | +$6.49M | 0.16% | 127 |
|
|
2024
Q4 | $77.3M | Buy |
944,205
+21,414
| +2% | +$1.78M | 0.15% | 148 |
|
|
2024
Q3 | $76.2M | Sell |
922,791
-293,610
| -24% | -$21.9M | 0.14% | 159 |
|
|
2024
Q2 | $85.4M | Buy |
1,216,401
+2,164
| +0.2% | +$155K | 0.16% | 134 |
|
|
2024
Q1 | $90M | Sell |
1,214,237
-46,521
| -4% | -$3.24M | 0.18% | 135 |
|
|
2023
Q4 | $83.4M | Sell |
1,260,758
-1,366,116
| -52% | -$85.5M | 0.18% | 129 |
|
|
2023
Q3 | $165M | Buy |
2,626,874
+22,727
| +0.9% | +$1.42M | 0.42% | 57 |
|
|
2023
Q2 | $147M | Sell |
2,604,147
-56,162
| -2% | -$3.12M | 0.34% | 68 |
|
|
2023
Q1 | $154M | Buy |
2,660,309
+211,543
| +9% | +$14.3M | 0.39% | 58 |
|
|
2022
Q4 | $177M | Buy |
2,448,766
+81,512
| +3% | +$5.84M | 0.48% | 47 |
|
|
2022
Q3 | $144M | Sell |
2,367,254
-14,699
| -0.6% | -$939K | 0.43% | 54 |
|
|
2022
Q2 | $149M | Sell |
2,381,953
-91,711
| -4% | -$6.07M | 0.47% | 52 |
|
|
2022
Q1 | $176M | Sell |
2,473,664
-163,674
| -6% | -$11.1M | 0.45% | 49 |
|
|
2021
Q4 | $165M | Sell |
2,637,338
-22,706
| -0.9% | -$1.43M | 0.36% | 72 |
|
|
2021
Q3 | $166M | Buy |
2,660,044
+2,234,494
| +525% | +$135M | 0.37% | 70 |
|
|
2021
Q2 | $25.5M | Sell |
425,550
-364,205
| -46% | -$23.1M | 0.06% | 304 |
|
|
2021
Q1 | $48M | Buy |
789,755
+343,766
| +77% | +$19M | 0.11% | 181 |
|
|
2020
Q4 | $20.9M | Buy |
445,989
+52,230
| +13% | +$2.26M | 0.05% | 308 |
|
|
2020
Q3 | $14.6M | Sell |
393,759
-40,336
| -9% | -$1.53M | 0.04% | 345 |
|
|
2020
Q2 | $15.9M | Sell |
434,095
-22,513
| -5% | -$784K | 0.04% | 337 |
|
|
2020
Q1 | $14M | Sell |
456,608
-685
| -0.1% | -$30.4K | 0.04% | 331 |
|
|
2019
Q4 | $23.3M | Sell |
457,293
-18,017
| -4% | -$870K | 0.06% | 309 |
|
|
2019
Q3 | $22.4M | Sell |
475,310
-55,432
| -10% | -$2.64M | 0.06% | 306 |
|
|
2019
Q2 | $26.4M | Sell |
530,742
-15,626
| -3% | -$734K | 0.06% | 306 |
|
|
2019
Q1 | $23.3M | Buy |
546,368
+112,854
| +26% | +$4.99M | 0.05% | 324 |
|
|
2018
Q4 | $17.8M | Sell |
433,514
-19,217
| -4% | -$825K | 0.04% | 344 |
|
|
2018
Q3 | $21.2M | Buy |
452,731
+25,038
| +6% | +$1.14M | 0.04% | 370 |
|
|
2018
Q2 | $18.6M | Buy |
427,693
+43,056
| +11% | +$2.01M | 0.04% | 382 |
|
|
2018
Q1 | $17.7M | Buy |
384,637
+17,521
| +5% | +$850K | 0.04% | 370 |
|
|
2017
Q4 | $18.6M | Sell |
367,116
-131
| -0% | -$6.9K | 0.04% | 365 |
|
|
2017
Q3 | $19.1M | Buy |
+367,247
| New | +$17.9M | 0.03% | 350 |
|
Other funds holding MET
Aberdeen Group's MET Position: Q2 2026 in Review
Aberdeen Group reduced its MetLife (MET) stake by 14% in Q2 2026, selling an estimated $11.2M and leaving 836,940 shares worth $70.8M. The position accounts for 0.1% of the portfolio, ranked #162.
Aberdeen Group first reported a position in MET in Q3 2017 and has held it in 36 quarters since. The position peaked at $177M in Q4 2022. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Aberdeen Group held 836,940 shares of MetLife worth $70.8M as of Q2 2026.
- Aberdeen Group sold 139,099 MetLife shares in Q2 2026, an estimated $11.2M.
- MetLife made up 0.1% of Aberdeen Group's portfolio in Q2 2026, its #162 holding.
- Aberdeen Group first reported a position in MetLife in Q3 2017 and has held it in 36 quarters since.
- Aberdeen Group's MetLife position peaked at $177M in Q4 2022.
- 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.